In addition, the result showed that HK3 had an apparent trend in predicting the efficacy of immunotherapy in patients receiving the PD‐1 monoclonal antibody treatment.
← all excerpts
HK3 is correlated with immune infiltrates and predicts response to immunotherapy in non-small cell lung cancer.
1
—
—